NCT06558487 The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
| NCT ID | NCT06558487 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Oncology |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-12-02 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-12-02 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.
Eligibility Criteria
Inclusion Criteria: * Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months. * Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit. Exclusion Criteria: * \<18 years old * Only received a surgical intervention as cancer treatment * Admitted to the ED for the surgical department
Contact & Investigator
Jason den Duijn
PRINCIPAL INVESTIGATOR
Erasmus Medical Center
Frequently Asked Questions
Who can join the NCT06558487 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06558487 currently recruiting?
Yes, NCT06558487 is actively recruiting participants. Contact the research team at j.denduijn@erasmusmc.nl for enrollment information.
Where is the NCT06558487 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands.
Who is sponsoring the NCT06558487 clinical trial?
NCT06558487 is sponsored by Erasmus Medical Center. The principal investigator is Jason den Duijn at Erasmus Medical Center. The trial plans to enroll 200 participants.